Elejalde syndrome

From WikiMD.com Medical Encyclopedia

Elejalde Syndrome[edit | edit source]

Diagram of autosomal recessive inheritance pattern

Elejalde syndrome, also known as neuroectodermal melanolysosomal disease, is a rare genetic disorder characterized by a combination of neurological, dermatological, and ocular abnormalities. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.

Clinical Features[edit | edit source]

Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

Pathophysiology[edit | edit source]

Elejalde syndrome is caused by mutations in genes involved in the development and function of melanosomes, which are specialized organelles responsible for the production and storage of melanin. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the lysosomal and melanosomal pathways.

Diagnosis[edit | edit source]

Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as Chediak-Higashi syndrome and Griscelli syndrome.

Management[edit | edit source]

There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include:

  • Neurological care: Anticonvulsant medications may be used to control seizures.
  • Dermatological care: Sun protection and skin care may be recommended to manage hypopigmentation.
  • Ophthalmological care: Regular eye examinations and corrective lenses may be necessary to address vision problems.

Genetic Counseling[edit | edit source]

Genetic counseling is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD